124 related articles for article (PubMed ID: 7529754)
1. Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial.
Epstein JB; Wong FL; Millner A; Le ND
Head Neck; 1994; 16(6):539-44. PubMed ID: 7529754
[TBL] [Abstract][Full Text] [Related]
2. Topical bleomycin for the treatment of dysplastic oral leukoplakia.
Epstein JB; Gorsky M; Wong FL; Millner A
Cancer; 1998 Aug; 83(4):629-34. PubMed ID: 9708924
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of oral leukoplakia with bleomycin.
Malmström M; Hietanen J; Sane J; Sysmäläinen M
Br J Oral Maxillofac Surg; 1988 Dec; 26(6):491-8. PubMed ID: 2462447
[TBL] [Abstract][Full Text] [Related]
4. Treatment of oral leukoplakia with topical bleomycin. A pilot study.
Wong F; Epstein J; Millner A
Cancer; 1989 Jul; 64(2):361-5. PubMed ID: 2472197
[TBL] [Abstract][Full Text] [Related]
5. Topical bleomycin in the treatment of oral leukoplakia: a pilot study.
Hammersley N; Ferguson MM; Rennie JS
Br J Oral Maxillofac Surg; 1985 Aug; 23(4):251-8. PubMed ID: 2412577
[TBL] [Abstract][Full Text] [Related]
6. Systemic and topical treatment of oral leukoplakia.
Sankaranarayanan R
Br J Oral Maxillofac Surg; 1989 Jun; 27(3):260-1. PubMed ID: 2472830
[No Abstract] [Full Text] [Related]
7. A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia.
Kuriakose MA; Ramdas K; Dey B; Iyer S; Rajan G; Elango KK; Suresh A; Ravindran D; Kumar RR; R P; Ramachandran S; Kumar NA; Thomas G; Somanathan T; Ravindran HK; Ranganathan K; Katakam SB; Parashuram S; Jayaprakash V; Pillai MR
Cancer Prev Res (Phila); 2016 Aug; 9(8):683-91. PubMed ID: 27267893
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of randomized trials for the treatment of oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
J Dent Educ; 2002 Aug; 66(8):896-902. PubMed ID: 12214837
[TBL] [Abstract][Full Text] [Related]
9. Topical application of vitamin A to oral leukoplakia: A clinical case series.
Epstein JB; Gorsky M
Cancer; 1999 Sep; 86(6):921-7. PubMed ID: 10491516
[TBL] [Abstract][Full Text] [Related]
10. [Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation].
Boisnic S; Branchet MC; Pascal F; Ben Slama L; Rostin M; Szpirglas H
Ann Dermatol Venereol; 1994; 121(6-7):459-63. PubMed ID: 7702278
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
Mulshine JL; Atkinson JC; Greer RO; Papadimitrakopoulou VA; Van Waes C; Rudy S; Martin JW; Steinberg SM; Liewehr DJ; Avis I; Linnoila RI; Hewitt S; Lippman SM; Frye R; Cavanaugh PF
Clin Cancer Res; 2004 Mar; 10(5):1565-73. PubMed ID: 15014005
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.
Nagao T; Warnakulasuriya S; Nakamura T; Kato S; Yamamoto K; Fukano H; Suzuki K; Shimozato K; Hashimoto S
Int J Cancer; 2015 Apr; 136(7):1708-17. PubMed ID: 25156040
[TBL] [Abstract][Full Text] [Related]
13. Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial.
Garewal HS; Katz RV; Meyskens F; Pitcock J; Morse D; Friedman S; Peng Y; Pendrys DG; Mayne S; Alberts D; Kiersch T; Graver E
Arch Otolaryngol Head Neck Surg; 1999 Dec; 125(12):1305-10. PubMed ID: 10604407
[TBL] [Abstract][Full Text] [Related]
14. The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin.
Tetè S; Pappalardo S; Rubini C; Salini L; Falco A; Perfetti EG
Minerva Stomatol; 1999 Sep; 48(9):411-8. PubMed ID: 10638174
[TBL] [Abstract][Full Text] [Related]
15. bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study.
Piattelli A; Fioroni M; Santinelli A; Rubini C
Oral Oncol; 1999 May; 35(3):314-20. PubMed ID: 10621853
[TBL] [Abstract][Full Text] [Related]
16. Topical agents for oral cancer chemoprevention: A systematic review of the literature.
Chau L; Jabara JT; Lai W; Svider PF; Warner BM; Lin HS; Raza SN; Fribley AM
Oral Oncol; 2017 Apr; 67():153-159. PubMed ID: 28351570
[TBL] [Abstract][Full Text] [Related]
17. [An effective case of local injection therapy of oral leukoplakia with bleomycin (author's transl)].
Hisano Y; Satoh T; Suzuki M; Kanai Y
Shigaku; 1978 Jun; 66(1):125-8. PubMed ID: 94664
[No Abstract] [Full Text] [Related]
18. Oral leukoplakia: open trial of topical therapy with calcipotriol compared with tretinoin.
Femiano F; Gombos F; Scully C; Battista C; Belnome G; Esposito V
Int J Oral Maxillofac Surg; 2001 Oct; 30(5):402-6. PubMed ID: 11720042
[TBL] [Abstract][Full Text] [Related]
19. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia.
Shafirstein G; Friedman A; Siegel E; Moreno M; Bäumler W; Fan CY; Morehead K; Vural E; Stack BC; Suen JY
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1117-23. PubMed ID: 22106236
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
